Vienna, February 14-17th 2018:
We are happy to announce that Defymed won the “Startup Grant for the Technology Fair” and is invited to participate to the 11th International ATTD (Advanced Technologies & Treatments for Diabetes) conference, taking place in Vienna, Austria. We will be located in booth #33 and will be very happy to meet you there! Our booth will be on the International Fair of New Technologies in Diabetes where start-ups and emerging companies will be displaying cutting edge technologies and medical devices for diabetes treatment. Moreover, Defymed’s CEO, Mrs Séverine SIGRIST and COO, Mr Richard Bouaoun, will be presenting the latest developments of both MailPan® and ExOlin® at :
- the session entitled: PRESENTATION OF START-UP COMPANIES on friday, 16 February 2018 from 09:00 to 09:10 in Hall L6.
- the “ATTD 2018 Technology Fair” on friday, 16 February 2018 from 12:50 to 13:00 in the Exhibition Area.
The conference on ATTD 2018 will present an outstanding scientific program delivered by renowned international experts. ATTD 2018 will showcase the latest developments in new insulin analogues and delivery systems, insulin pumps, glucose sensors, closed-loop systems, devices for diabetic prevention, artificial pancreas, new technologies for treating obesity and many more.
For more info